Ignite Creation Date:
2024-05-06 @ 2:55 PM
Last Modification Date:
2024-10-26 @ 1:39 PM
Study NCT ID:
NCT04461782
Status:
COMPLETED
Last Update Posted:
2020-07-08
First Post:
2020-06-02
Brief Title:
Interventional Study to Evaluate the Effect of the Oral Administration of LPlantarum on Vaginal Microbiota
Sponsor:
AB Biotics SA
Organization:
AB Biotics SA
Study Overview
Official Title:
Interventional Study to Evaluate the Effect of a Food Supplement Comprising L Plantarum After Oral Intake in Vaginal Microbiota
Status:
COMPLETED
Status Verified Date:
2020-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Vaginal microbiota is abundantly colonized by Lactobacillus genera When vaginal microbiota gets altered opportunistic microorganisms may proliferate and become abundant species giving rise to dysbiosis
Probiotics are living organisms that provide the host certain benefits Despite probiotics have been historically linked to intestinal microbiota several research groups have published positive results for some Lactobacillus strains in vaginal microbiota The Lactobacillus strain investigated in the presented project showed the ability to prevent recurrent vaginal Candidiasis in women with high vaginal candidiasis prevalence
Nowadays the Lactobacillus strain here investigated is commercialized as vaginal caps however oral intake is widely preferred among consumers Because of that this study aims to determine whether this Lactobacillus strain is able to colonize vaginal microbiota when administered orally
Probiotics are living organisms that provide the host certain benefits Despite probiotics have been historically linked to intestinal microbiota several research groups have published positive results for some Lactobacillus strains in vaginal microbiota The Lactobacillus strain investigated in the presented project showed the ability to prevent recurrent vaginal Candidiasis in women with high vaginal candidiasis prevalence
Nowadays the Lactobacillus strain here investigated is commercialized as vaginal caps however oral intake is widely preferred among consumers Because of that this study aims to determine whether this Lactobacillus strain is able to colonize vaginal microbiota when administered orally
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None